TRDA — Entrada Therapeutics, Inc.

Ownership history in MPM ASSET MANAGEMENT LLC  ·  16 quarters on record

This page tracks every 13F SEC filing in which MPM ASSET MANAGEMENT LLC reported a position in Entrada Therapeutics, Inc. (TRDA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
67.92% (2025 Q2)
Avg. % of fund
36.66%
First filed
2021 Q4
Last filed
2025 Q3
Quarters held
16
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 4,381,062 — 0% 57.09% $25.4M $5.80
2025 Q2 UNCHANGED 4,381,062 — 0% 67.92% $29.44B $6.72
2025 Q1 UNCHANGED 4,381,062 — 0% 57.04% $39.6M $9.04
2024 Q4 REDUCED 4,381,062 -44,722 -1.0% 60.89% $75.7M $17.29
12 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    TRDA price (monthly, adj. close)

Other funds also holding TRDA

As of 2025 Q4 — sorted by position size

5AM Venture Management, LLC 3Y 13.11% StepStone Group LP 3Y 7Y 4.19% TCG Crossover Management, LLC 3Y 0.71% Nan Fung Group Holdings Ltd 3Y 0.45% BAKER BROS. ADVISORS LP 3Y 7Y 0.31% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 0.22% Lynx1 Capital Management LP 3Y 0.11% Dynamic Technology Lab Private Ltd 3Y 7Y 0.06% XTX Topco Ltd 3Y 0.03% ROYCE & ASSOCIATES LP 3Y 7Y 0.03%
← Back to MPM ASSET MANAGEMENT LLC Holdings